Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Guangzhou Pharmaceutical Company Limited Announces FY 2011 Dividend Payment
Guangzhou Pharmaceutical Company Limited announced that it will pay a cash dividend of RMB 0.10 per share (pre-tax) to shareholders for fiscal year 2011.
Latest Developments for Guangzhou Pharmaceutical Co Ltd
- Guangzhou Pharmaceutical Co Ltd Proposes Change Of Auditors
- Guangzhou Pharmaceutical Co Ltd Updates Merger with Guangzhou Baiyunshan Pharmaceutical Co Ltd
- Guangzhou Pharmaceutical Co Ltd Announces No Dividend Payment for FY 2012
- Guangzhou Pharmaceutical Company Limited to Acquire Guangzhou Baiyunshan Pharmaceutical Co.
Latest Key Developments in Pharmaceuticals
- Herbalife Ltd Engages PricewaterhouseCoopers LLP As Auditors
- Baxter International Inc Receives Marketing Authorization For Hyqvia In European Union
- AMAG Pharmaceuticals Inc Announces Ferumoxytol Treatment Produced Hemoglobin Increases In Adult Iron Deficiency Anemia Patients With Gastrointestinal Disease
- Sanofi SA and Regeneron Pharmaceuticals Inc Announce Positive Phase 2a Results of Dupilumab in Asthma
- Share this
- Link this
- Digg this
Follow Reuters